CoChat
Sign Up
Cited by 259COVID-19 Clinical Research StudiesDiabetes Treatment and ManagementMetabolism, Diabetes, and Cancer

The DOI matches its Crossref record; 15 of the 16 references it cites were found in a registry or an index.

Metformin Treatment Was Associated with Decreased Mortality in COVID-19 Patients with Diabetes in a Retrospective Analysis

Open access
Luo, Pan, Qiu, Lin, Liu, Yi, Liu, Xiu-lan, Zheng, Jian-ling, Xue, Hui-ying, Liu, Wen-hua, Liu, Dong, Li, Juan·2020·The American Journal of Tropical Medicine and Hygiene
DOI 10.4269/ajtmh.20-0375PMC PMC7356425
Open this paper in CoChat — free accountOpen PDF

Abstract

Metformin was proposed to be a candidate for host-directed therapy for COVID-19. However, its efficacy remains to be validated. In this study, we compared the outcome of metformin users and nonusers in hospitalized COVID-19 patients with diabetes. Hospitalized diabetic patients with confirmed COVID-19 in the Tongji Hospital of Wuhan, China, from January 27, 2020 to March 24, 2020, were grouped into metformin and no-metformin groups according to the diabetic medications used. The demographics, characteristics, laboratory parameters, treatments, and clinical outcome in these patients were retrospectively assessed. A total of 283 patients (104 in the metformin and 179 in the no-metformin group) were included in this study. There were no significant differences between the two groups in gender, age, underlying diseases, clinical severity, and oxygen-support category at admission. The fasting blood glucose level of the metformin group was higher than that of the no-metformin group at admission and was under effective control in both groups after admission. Other laboratory parameters at admission and treatments after admission were not different between the two groups. The length of hospital stay did not differ between the two groups (21.0 days for metformin versus 19.5 days for no metformin, P = 0.74). However, in-hospital mortality was significantly lower in the metformin group (3/104 (2.9%) versus 22/179 (12.3%), P = 0.01). Antidiabetic treatment with metformin was associated with decreased mortality compared with diabetics not receiving metformin. This retrospective analysis suggests that metformin may offer benefits in patients with COVID-19 and that further study is indicated.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.4269/ajtmh.20-0375

Cites

15 of 15 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 16 references

Cited by

Sorted by citations

Items 201–259 of 259

Related

See all

Metadata

Authors
Luo, P., Qiu, L., Liu, Y., Liu, X.-L., Zheng, J.-L., Xue, H.-Y., Liu, W.-H., Liu, D., & Li, J.
Affiliations
  • Tongji Hospital (CN)
  • Clinical Research Center, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China
Corresponding author
  • Liu, Yi
  • Liu, Xiu-lan
  • Liu, Dong
  • Li, Juan
ORCID
Venue
The American Journal of Tropical Medicine and Hygiene
Publisher
American Society of Tropical Medicine and Hygiene
Published
2020-07-08
Volume
103
Issue
1
Pages
69-72
ISSN
  • 0002-9637 (ISSN-L)
  • 1476-1645
DOI
10.4269/ajtmh.20-0375
PMC
PMC7356425
OpenAlex
W3027187955
Cited by
259
References
16
Citations by year
2026: 3 · 2025: 7 · 2024: 17 · 2023: 32 · 2022: 62 · 2021: 83 · 2020: 55
FWCI
7.61
Type
journal article
Language
en
Open access
Locations
  • American Journal of Tropical Medicine and Hygiene (publishedVersion)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Infectious Diseases › COVID-19 Clinical Research Studies
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
Keywords
metformin, COVID-19 pandemic, diabetes mellitus, in-hospital mortality, antidiabetic therapy, hospitalized patients, host-directed therapy, length of hospital stay
MeSH terms
Betacoronavirus, COVID-19, SARS-CoV-2, Aged, China, Diabetes Mellitus, Type 2, Female, Humans, Hypoglycemic Agents, Length of Stay, Male, Metformin, Middle Aged, Pneumonia, Viral, Retrospective Studies, Hospital Mortality, Coronavirus Infections, Pandemics

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review